Are you living with HIV?
Have you been taking DOVATO® (dolutegravir/lamivudine) treatment for more than 3 months?
If so, you may qualify to take a 30 minute online survey about your experiences. The survey is part of research being done to help better understand how people feel about living with HIV and the impact (good or bad) DOVATO® treatment has on life overall. People who qualify and complete the survey will receive $50 as a thank you.
Would you qualify?
People must meet the following criteria:
aged 18 or over
diagnosed with HIV by a medical professional
currently taking DOVATO® (dolutegravir/lamivudine)
received a different treatment for HIV in the past
be a resident of the US
To see if you qualify or to get more information please fill out this form and we will contact you within 24-48 hours. If you have questions about the study please email Kathryn Goodfellow (email@example.com). Please note that due to the nature of the study you may be asked for proof of DOVATO use.